The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries

Cancer Causes and Control

Volumn 24, Issue 2, 2013, Pages 241-248

  Flores Luna, L ^a   Camorlinga Ponce, M ^b   Hernandez Suarez, G ^c   Kasamatsu, E ^d   Martinez M E ^e   Murillo, R ^c   Lazcano, E ^a   Torres, J ^b  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c Instituto Nacional de Cancerología   (Colombia)

^d Instituto de Investigaciones en Ciencias de la Salud Universidad Nacional de Asuncion   (Paraguay)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

CagA; Gastric cancer; Gastric preneoplastic lesions; Helicobacter pylori; Serologic biomarkers

Indexed keywords

BIOLOGICAL MARKER; CAGA PROTEIN; CELL ANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER MORTALITY; CANCER RISK; COLOMBIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEXICO; PARAGUAY; PRECANCER; PRIORITY JOURNAL; SEROLOGY; SOUTH AND CENTRAL AMERICA; STOMACH BIOPSY; STOMACH CANCER; TUMOR DIFFERENTIATION;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878862250     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0106-8     Document Type: Article

References (35)

1. Lochhead P, El-Omar EM (2008) Gastric cancer. Br Med Bull 85:87-100
2. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM (2010) The global burden of cancer: priorities for prevention. Carcinogenesis 31:100-110
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
4. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, et al. (2009) Recent patterns in gastric cancer: a global overview. Int J Cancer 125:666-673
5. Hatakeyama M (2011) Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein. Cancer Sci 102:36-43
6. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, et al. (2008) Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 105:1003-1008
7. Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D (2004) Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 159:252-258
8. Suriani R, Colozza M, Cardesi E, Mazzucco D, Marino M, et al. (2008) CagA and VacA Helicobacter pylori antibodies in gastric cancer. Can J Gastroenterol 22:255-258
9. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, et al. (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111-2115
10. Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MK, et al. (1995) Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol 33:1496-1500
11. Mattar R, Marques SB, Monteiro Mdo S, Dos Santos AF, Iriya K, et al. (2007) Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil. J Med Microbiol 56:9-14
12. Shiota S, Matsunari O, Watada M, Yamaoka Y (2010) Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol 5:1885-1893
13. Webb PM, Crabtree JE, Forman D (1999) Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group. Gastroenterology 116:269-276
14. Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagun F, et al. (2008) Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Cancer Epidemiol Biomarkers Prev 17:2498-2504
15. Camorlinga-Ponce M, Torres J, Perez-Perez G, Leal-Herrera Y, Gonzalez-Ortiz B, et al. (1998) Validation of a serologic test for the diagnosis of Helicobacter pylori infection and the immune response to urease and CagA in children. Am J Gastroenterol 93:1264-1270
16. Ferreccio C, Rollán A, Harris PR, Serrano C, Gederlini A, et al. (2007) Gastric cancer is related to early Helicobacter pylori infection in a high-prevalence country. Cancer Epidemiol Biomarkers Prev 16:662-667
17. Plummer M, van Doorn LJ, Franceschi S, Kleter B, Canzian F, et al. (2007) Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst 99:1328-1334
18. Camargo MC, Yepez MC, Ceron C, Guerrero N, Bravo LE, et al. (2004) Age at acquisition of Helicobacter pylori infection: comparison of two areas with contrasting risk of gastric cancer. Helicobacter 9:262-270
19. Kasamatsu E, Bravo LE, Bravo JC, Aguirre-Garcia J, Flores-Luna L, et al. (2010) Reproducibility of histopathologic diagnosis of precursor lesions of gastric carcinoma in three Latin American countries. Salud Publica Mex 52:386-390
20. Torres J, Camorlinga-Ponce M, Perez-Perez G, Munoz L, Munoz O (2002) Specific serum immunoglobulin G response to urease and CagA antigens of Helicobacter pylori in infected children and adults in a country with high prevalence of infection. Clin Diagn Lab Immunol 9:97-100
21. Hsu PI, Lai KH, Tseng HH, Liu YC, Yen MY, et al. (1997) Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. J Clin Gastroenterol 25:587-591
22. Yanaoka K, Oka M, Yoshimura N, Mukoubayashi C, Enomoto S, et al. (2008) Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels. Int J Cancer 123:917-926
23. Chen TS, Li FY, Chang FY, Lee SD (2002) Immunoglobulin G antibody against Helicobacter pylori: clinical implications of levels found in serum. Clin Diagn Lab Immunol 9:1044-1048
24. Graham DY, Genta RM, Graham DP, Crabtree JE (1996) Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol 49:829-832
25. Bedoya A, Garay J, Sanzon F, Bravo LE, Bravo JC, et al. (2003) Histopathology of gastritis in Helicobacter pylori-infected children from populations at high and low gastric cancer risk. Hum Pathol 34:206-213
26. Munoz L, Camorlinga M, Hernandez R, Giono S, Ramon G, et al. (2007) Immune and proliferative cellular responses to Helicobacter pylori infection in the gastric mucosa of Mexican children. Helicobacter 12:224-230
27. Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Harkonen M, et al. (2003) Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 111:619-624
28. Klaamas K, Held M, Wadstrom T, Lipping A, Kurtenkov O (1996) IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 67:1-5
29. Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, et al. (1996) Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev 5:627-630
30. Con SA, Con-Wong R, Con-Chin GR, Con-Chin VG, Takeuchi H, et al. (2007) Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica. Cancer Epidemiol Biomarkers Prev 16:2631-2636
31. Meine GC, Rota C, Dietz J, Sekine S, Prolla JC (2011) Relationship between cagA-positive Helicobacter pylori infection and risk of gastric cancer: a case control study in Porto Alegre, RS, Brazil. Arq Gastroenterol 48:41-45
32. Tatemichi M, Hamada GS, Nishimoto IN, Kowalski LP, Iriya K, et al. (2003) Ethnic difference in serology of Helicobacter pylori CagA between Japanese and non-Japanese Brazilians for non-cardia gastric cancer. Cancer Sci 94:64-69
33. Nomura AM, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, et al. (2002) Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis 186:1138-1144
34. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, et al. (1995) Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 73:760-770
35. Pan ZJ, van der Hulst RW, Feller M, Xiao SD, Tytgat GN, et al. (1997) Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol 35:1344-1347